莱茵生物: 第七届董事会第六次会议决议公告

Core Viewpoint - The company plans to permanently supplement its working capital with surplus funds from completed investment projects, aiming to alleviate financial pressure and optimize its financial structure [2][3]. Group 1: Board Meeting Details - The seventh board meeting was held on August 20, 2025, with all seven participating directors present, ensuring compliance with relevant laws and regulations [2]. - The board made several resolutions, including the conclusion of the "Stevia Professional Extraction Factory Construction Project" and the "Rhein Natural Health Products Research Institute Construction Project" [2][3]. Group 2: Financial Decisions - The company intends to use a total of 315.34 million yuan from surplus funds and estimated outstanding project payments to permanently supplement its working capital [2][3]. - The board believes that this move will help ease financial pressure, optimize the financial structure, and enhance the company's risk resistance capabilities [3]. Group 3: Financing Initiatives - The company plans to engage in financing leaseback transactions with qualified leasing institutions, with a total financing amount not exceeding 300 million yuan [3]. - A temporary shareholders' meeting is scheduled for September 9, 2025, to discuss further corporate matters [3][4].